Biolaser ApS: Financial statements 2024
CVR: 21333271
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Biolaser ApS (CVR 21333271) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 209,010 and a net result of DKK 82,521 compared with DKK -36,597 the year before. Equity in the 2024 report amounted to DKK 827,065. The solvency ratio was 72.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 209,010
- Profit/Loss
- DKK 82,521
- Equity
- DKK 827,065
- Total Assets
- DKK 1,135,647
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 209 t. | 83 t. | 827 t. | 1 |
| 2023 | - | -47 t. | -37 t. | 745 t. | - |
| 2022 | - | 614 t. | 479 t. | 1.3 mio. | - |
| 2021 | - | 318 t. | 248 t. | 1.1 mio. | 0 |
| 2020 | - | -10 t. | -169 t. | 1 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Biolaser ApS has published its annual report for 2023. Gross profit came to DKK -46,629, and the net result was DKK -36,597.
About Biolaser ApS
Biolaser ApS is a Danish company of the type Anpartsselskab based in Fjerritslev, founded in 1998. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Caitanya Candradasa. The company is owned by Caitanya Candradasa. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -133,181 and a net result of DKK -141,615 compared with DKK 82,521 the year before. Equity in the 2025 report amounted to DKK 685,450.